Commonwealth Bank of Australia’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-8,619
| Closed | -$527K | – | 333 |
|
2019
Q2 | $527K | Buy |
8,619
+1,884
| +28% | +$115K | 0.01% | 718 |
|
2019
Q1 | $428K | Sell |
6,735
-160,827
| -96% | -$10.2M | ﹤0.01% | 668 |
|
2018
Q4 | $8.55M | Sell |
167,562
-141,852
| -46% | -$7.24M | 0.09% | 140 |
|
2018
Q3 | $18M | Buy |
309,414
+2,439
| +0.8% | +$142K | 0.17% | 92 |
|
2018
Q2 | $14.9M | Buy |
306,975
+252
| +0.1% | +$12.2K | 0.15% | 101 |
|
2018
Q1 | $14.3M | Sell |
306,723
-506,919
| -62% | -$23.6M | 0.15% | 111 |
|
2017
Q4 | $30.6M | Buy |
813,642
+616,737
| +313% | +$23.2M | 0.3% | 71 |
|
2017
Q3 | $7.08M | Buy |
196,905
+16,416
| +9% | +$590K | 0.07% | 192 |
|
2017
Q2 | $7.11M | Sell |
180,489
-228,651
| -56% | -$9.01M | 0.07% | 179 |
|
2017
Q1 | $12.8M | Buy |
409,140
+80,511
| +24% | +$2.52M | 0.14% | 112 |
|
2016
Q4 | $10.3M | Buy |
328,629
+187,728
| +133% | +$5.86M | 0.13% | 123 |
|
2016
Q3 | $5.66M | Sell |
140,901
-21,906
| -13% | -$880K | 0.07% | 167 |
|
2016
Q2 | $5.41M | Buy |
162,807
+26,175
| +19% | +$870K | 0.06% | 175 |
|
2016
Q1 | $4.02M | Buy |
136,632
+237
| +0.2% | +$6.97K | 0.05% | 215 |
|
2015
Q4 | $3.59M | Buy |
136,395
+315
| +0.2% | +$8.3K | 0.05% | 215 |
|
2015
Q3 | $3.22M | Buy |
136,080
+5,616
| +4% | +$133K | 0.04% | 230 |
|
2015
Q2 | $3.1M | Buy |
130,464
+18,888
| +17% | +$448K | 0.04% | 213 |
|
2015
Q1 | $2.65M | Buy |
111,576
+107,976
| +2,999% | +$2.56M | 0.04% | 252 |
|
2014
Q4 | $76K | Hold |
3,600
| – | – | ﹤0.01% | 607 |
|
2014
Q3 | $61K | Hold |
3,600
| – | – | ﹤0.01% | 727 |
|
2014
Q2 | $52K | Sell |
3,600
-256,032
| -99% | -$3.7M | ﹤0.01% | 747 |
|
2014
Q1 | $3.21M | Buy |
259,632
+214,632
| +477% | +$2.65M | 0.02% | 548 |
|
2013
Q4 | $493K | Buy |
45,000
+3,600
| +9% | +$39.4K | ﹤0.01% | 1014 |
|
2013
Q3 | $480K | Hold |
41,400
| – | – | ﹤0.01% | 984 |
|
2013
Q2 | $464K | Buy |
+41,400
| New | +$464K | ﹤0.01% | 968 |
|